162 related articles for article (PubMed ID: 11825564)
1. A CD40 Signalosome anchored in lipid rafts leads to constitutive activation of NF-kappaB and autonomous cell growth in B cell lymphomas.
Pham LV; Tamayo AT; Yoshimura LC; Lo P; Terry N; Reid PS; Ford RJ
Immunity; 2002 Jan; 16(1):37-50. PubMed ID: 11825564
[TBL] [Abstract][Full Text] [Related]
2. Activation-induced cell death of aggressive histology lymphomas by CD40 stimulation: induction of bax.
Szocinski JL; Khaled AR; Hixon J; Halverson D; Funakoshi S; Fanslow WC; Boyd A; Taub DD; Durum SK; Siegall CB; Longo DL; Murphy WJ
Blood; 2002 Jul; 100(1):217-23. PubMed ID: 12070030
[TBL] [Abstract][Full Text] [Related]
3. Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells.
Furman RR; Asgary Z; Mascarenhas JO; Liou HC; Schattner EJ
J Immunol; 2000 Feb; 164(4):2200-6. PubMed ID: 10657675
[TBL] [Abstract][Full Text] [Related]
4. Localization in situ of costimulatory molecules and cytokines in B-cell non-Hodgkin's lymphoma.
Vyth-Dreese FA; Boot H; Dellemijn TA; Majoor DM; Oomen LC; Laman JD; Van Meurs M; De Weger RA; De Jong D
Immunology; 1998 Aug; 94(4):580-6. PubMed ID: 9767448
[TBL] [Abstract][Full Text] [Related]
5. Constitutive NF-kappaB and NFAT activation in aggressive B-cell lymphomas synergistically activates the CD154 gene and maintains lymphoma cell survival.
Pham LV; Tamayo AT; Yoshimura LC; Lin-Lee YC; Ford RJ
Blood; 2005 Dec; 106(12):3940-7. PubMed ID: 16099873
[TBL] [Abstract][Full Text] [Related]
6. CD40 engagement prevents peroxisome proliferator-activated receptor gamma agonist-induced apoptosis of B lymphocytes and B lymphoma cells by an NF-kappaB-dependent mechanism.
Ray DM; Akbiyik F; Bernstein SH; Phipps RP
J Immunol; 2005 Apr; 174(7):4060-9. PubMed ID: 15778364
[TBL] [Abstract][Full Text] [Related]
7. B cell receptor (BCR) cross-talk: CD40 engagement creates an alternate pathway for BCR signaling that activates I kappa B kinase/I kappa B alpha/NF-kappa B without the need for PI3K and phospholipase C gamma.
Mizuno T; Rothstein TL
J Immunol; 2005 May; 174(10):6062-70. PubMed ID: 15879100
[TBL] [Abstract][Full Text] [Related]
8. Constitutive NF-kappaB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas.
Fu L; Lin-Lee YC; Pham LV; Tamayo A; Yoshimura L; Ford RJ
Blood; 2006 Jun; 107(11):4540-8. PubMed ID: 16497967
[TBL] [Abstract][Full Text] [Related]
9. Membrane-bound CD154, but not CD40-specific antibody, mediates NF-kappaB-independent IL-6 production in B cells.
Baccam M; Bishop GA
Eur J Immunol; 1999 Dec; 29(12):3855-66. PubMed ID: 10601993
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human B-cell lymphoma growth by CD40 stimulation.
Funakoshi S; Longo DL; Beckwith M; Conley DK; Tsarfaty G; Tsarfaty I; Armitage RJ; Fanslow WC; Spriggs MK; Murphy WJ
Blood; 1994 May; 83(10):2787-94. PubMed ID: 7514045
[TBL] [Abstract][Full Text] [Related]
11. NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes.
Lee HH; Dadgostar H; Cheng Q; Shu J; Cheng G
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9136-41. PubMed ID: 10430908
[TBL] [Abstract][Full Text] [Related]
12. Increased inhibition of proliferation of human B cell lymphomas following ligation of CD40, and either CD19, CD20, CD95 or surface immunoglobulin.
Benoit NE; Wade WF
Immunopharmacology; 1996 Nov; 35(2):129-39. PubMed ID: 8956976
[TBL] [Abstract][Full Text] [Related]
13. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
[TBL] [Abstract][Full Text] [Related]
14. CD40 activates NF-kappa B and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells.
Schwabe RF; Schnabl B; Kweon YO; Brenner DA
J Immunol; 2001 Jun; 166(11):6812-9. PubMed ID: 11359840
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity to Fas-mediated apoptosis is null or weak in B-cell non-Hodgkin's lymphomas and is moderately increased by CD40 ligation.
Xerri L; Bouabdallah R; Devilard E; Hassoun J; Stoppa AM; Birg F
Br J Cancer; 1998 Jul; 78(2):225-32. PubMed ID: 9683298
[TBL] [Abstract][Full Text] [Related]
16. Transgenic expression of CD40L and interleukin-2 induces an autologous antitumor immune response in patients with non-Hodgkin's lymphoma.
Takahashi S; Yotnda P; Rousseau RF; Mei Z; Smith S; Rill D; Younes A; Brenner MK
Cancer Gene Ther; 2001 May; 8(5):378-87. PubMed ID: 11477458
[TBL] [Abstract][Full Text] [Related]
17. CD40 ligation conditions dendritic cell antigen-presenting function through sustained activation of NF-kappaB.
O'Sullivan BJ; Thomas R
J Immunol; 2002 Jun; 168(11):5491-8. PubMed ID: 12023343
[TBL] [Abstract][Full Text] [Related]
18. The influence of CD40 on the association of the B cell antigen receptor with lipid rafts in mature and immature cells.
Malapati S; Pierce SK
Eur J Immunol; 2001 Dec; 31(12):3789-97. PubMed ID: 11745400
[TBL] [Abstract][Full Text] [Related]
19. CD40 ligand in CLL pathogenesis and therapy.
Schattner EJ
Leuk Lymphoma; 2000 May; 37(5-6):461-72. PubMed ID: 11042507
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis.
Pham LV; Tamayo AT; Yoshimura LC; Lo P; Ford RJ
J Immunol; 2003 Jul; 171(1):88-95. PubMed ID: 12816986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
